Reviva Pharmaceuticals Holdings, Inc.: Form SCHEDULE 13D/A, filed Jan 31, 2025
Filed with the SEC on Jan 31, 2025 and accepted by EDGAR at Jan 31, 2025, 21:31 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-25-004530. Last ingested by Listed: Oct 29, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.